231 related articles for article (PubMed ID: 28646526)
21. Lombardy diagnostic and therapeutic network of thrombotic microangiopathy.
Mancini I; Agosti P; Boscarino M; Ferrari B; Artoni A; Palla R; Spreafico M; Crovetti G; Volpato E; Rossini S; Novelli C; Gattillo S; Barcella L; Salmoiraghi M; Falanga A; Peyvandi F;
Orphanet J Rare Dis; 2022 Jun; 17(1):246. PubMed ID: 35739601
[TBL] [Abstract][Full Text] [Related]
22. Comparison of Clinical Scoring Systems in the Management of Patients with Microangiopathic Hemolytic Anemia and Thrombocytopenia.
Baysal M; Ümit E; Kırkızlar HO; Demir AM
Turk J Haematol; 2021 Feb; 38(1):64-68. PubMed ID: 33161686
[TBL] [Abstract][Full Text] [Related]
23. Potential modifications of the PLASMIC scoring system for predicting thrombotic thrombocytopenic purpura: Sometimes, less is more.
Orhan B; Özkocaman V; Akdemir Ç; Ersal T; Pınar İE; Yalçın C; Candar Ö; Çubukçu S; Koca TG; Ambarcıoğlu P; Ali R; Özkalemkaş F
Int J Lab Hematol; 2023 Oct; 45(5):751-757. PubMed ID: 37309683
[TBL] [Abstract][Full Text] [Related]
24. Plasmic score applicability for the diagnosis of thrombotic microangiopathy associated with ADAMTS13-acquired deficiency in a developing country.
Oliveira DS; Lima TG; Benevides FLN; Barbosa SAT; Oliveira MA; Boris NP; Silva HF
Hematol Transfus Cell Ther; 2019; 41(2):119-124. PubMed ID: 31079658
[TBL] [Abstract][Full Text] [Related]
25. Development and validation of a multivariable prediction rule for detecting a severe acquired ADAMTS13 activity deficiency in patients with thrombotic microangiopathies.
Nieto JM; De La Fuente-Gonzalo F; González FA; Villegas A; Martínez R; Fuentes ME; Ropero P
Clin Chem Lab Med; 2018 Jan; 56(2):294-302. PubMed ID: 28796639
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of thrombotic thrombocytopenic purpura and other thrombotic microangiopathies: Lessons learned from a 14-year retrospective study.
Tau J; Fernando LP; Munoz MC; Poh C; Krishnan VV; Dwyre DM
Ther Apher Dial; 2023 Feb; 27(1):136-145. PubMed ID: 35501999
[TBL] [Abstract][Full Text] [Related]
27. Thrombotic microangiopathies.
Rosove MH
Semin Arthritis Rheum; 2014 Jun; 43(6):797-805. PubMed ID: 24360024
[TBL] [Abstract][Full Text] [Related]
28. Immune Thrombotic Thrombocytopenic Purpura in Elderly Patients: The Roles of PLASMIC and French Scores.
Baysal M; Hindilerden F; Ümit EG; Demir AM; Keklik Karadağ F; Saydam G; Akpınar S; Turgut B; Özkocaman V; Özkalemkaş F; Çiftçiler R; Özlü C; Demircioğlu S; İpek Y; Diz Küçükkaya R
Turk J Haematol; 2023 Dec; 40(4):251-257. PubMed ID: 37791641
[TBL] [Abstract][Full Text] [Related]
29. Application of PLASMIC score in prediction of ADAMTS13 deficiency in a pediatric case of acquired thrombotic thrombocytopenic purpura.
Gupta GK; Hendrickson JE; Tormey CA
J Clin Apher; 2020 Apr; 35(2):140-141. PubMed ID: 31951292
[No Abstract] [Full Text] [Related]
30. Use of the ADAMTS13 activity assay improved the accuracy and efficiency of the diagnosis and treatment of suspected acquired thrombotic thrombocytopenic purpura.
Barrows BD; Teruya J
Arch Pathol Lab Med; 2014 Apr; 138(4):546-9. PubMed ID: 24678685
[TBL] [Abstract][Full Text] [Related]
31. Utility of Different Scoring Systems for the Diagnosis of Thrombotic Microangiopathies.
Yilmaz S; Cenelİ O; Tekinalp A
J Coll Physicians Surg Pak; 2023 May; 33(5):539-543. PubMed ID: 37190689
[TBL] [Abstract][Full Text] [Related]
32. Implementation of a rapid assay of ADAMTS13 activity was associated with improved 30-day survival rate in patients with acquired primary thrombotic thrombocytopenic purpura who received platelet transfusions.
Yoshii Y; Fujimura Y; Bennett CL; Isonishi A; Kurumatani N; Matsumoto M
Transfusion; 2017 Aug; 57(8):2045-2053. PubMed ID: 28500622
[TBL] [Abstract][Full Text] [Related]
33. Impact of severe ADAMTS13 deficiency on clinical presentation and outcomes in patients with thrombotic microangiopathies: the experience of the Harvard TMA Research Collaborative.
Bendapudi PK; Li A; Hamdan A; Uhl L; Kaufman R; Stowell C; Dzik W; Makar RS
Br J Haematol; 2015 Dec; 171(5):836-44. PubMed ID: 26314936
[TBL] [Abstract][Full Text] [Related]
34. Atypical presentations of thrombotic thrombocytopenic purpura: a diagnostic role for ADAMTS13.
Kalish Y; Rottenstreich A; Rund D; Hochberg-Klein S
J Thromb Thrombolysis; 2016 Aug; 42(2):155-60. PubMed ID: 26867546
[TBL] [Abstract][Full Text] [Related]
35. Clinical and laboratory diagnosis of TTP: an integrated approach.
Chiasakul T; Cuker A
Hematology Am Soc Hematol Educ Program; 2018 Nov; 2018(1):530-538. PubMed ID: 30504354
[TBL] [Abstract][Full Text] [Related]
36. Current management of thrombotic thrombocytopenic purpura.
Kremer Hovinga JA; Meyer SC
Curr Opin Hematol; 2008 Sep; 15(5):445-50. PubMed ID: 18695366
[TBL] [Abstract][Full Text] [Related]
37. Inherited thrombotic thrombocytopenic purpura mimicking immune thrombocytopenic purpura during pregnancy: a case report.
Romão de Souza V; Beatriz Cavalcante de Oliveira A; Maria Vanderlei A; Queiroz da Mota Silveira Aroucha A; Pontes Duarte B; Nunes Machado A; Netto Chaer L; Wanderley de Barros Correia C; da Conceição de Barros Correia M; Freire Hazin Costa M
J Med Case Rep; 2018 Jan; 12(1):15. PubMed ID: 29357939
[TBL] [Abstract][Full Text] [Related]
38. Effect of ADAMTS13 activity turnaround time on plasma utilization for suspected thrombotic thrombocytopenic purpura.
Connell NT; Cheves T; Sweeney JD
Transfusion; 2016 Feb; 56(2):354-9. PubMed ID: 26456149
[TBL] [Abstract][Full Text] [Related]
39. ADAMTS13 Testing Methodologies and Thrombotic Thrombocytopenic Purpura (TTP): Conflicting Results Can Pose a Clinical Dilemma.
Pandey S; Cottler-Fox M
Ann Clin Lab Sci; 2018 May; 48(3):373-376. PubMed ID: 29970443
[TBL] [Abstract][Full Text] [Related]
40. ISTH guidelines for the diagnosis of thrombotic thrombocytopenic purpura.
Zheng XL; Vesely SK; Cataland SR; Coppo P; Geldziler B; Iorio A; Matsumoto M; Mustafa RA; Pai M; Rock G; Russell L; Tarawneh R; Valdes J; Peyvandi F
J Thromb Haemost; 2020 Oct; 18(10):2486-2495. PubMed ID: 32914582
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
